Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis expressed transcript, Y-linked 3 (TTTY3) is a long intergenic non-protein coding RNA (lincRNA) gene located on the Y chromosome with testis-specific expression. It does not code for a protein product and belongs to the family of long non-coding RNAs, whose general functions include chromatin remodeling and regulation of gene expression, often in a tissue-specific manner. There is limited information on any direct therapeutic or biomarker relevance for TTTY3 itself. TTTY3 has two copies within the P1 palindrome on the Y chromosome, and diseases reported in association with TTTY3 are rare congenital disorders; current data do not implicate it as a major disease gene or therapeutic target[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis expressed transcript, Y-linked 3 (TTTY3).